Table 1.

Cognitive outcome measures

Outcome measure	Reference for studies used	Diagnostic utility	Inter‐rater reliability	Test‐retest reliability	Responsiveness	Clinically meaningful change	Endorsement
ADAS‐cog	25, 26, 27, 28, 33, 34, 36, and 37	NE	High	Moderate to high	Yes	4 points	Recommended
MDRS	23, 31, 32, and 37	High	High	High	Yes	NE	Recommended
MoCA	Not used	Moderate	High	High	Yes	NE	Suggested
CDR	25, 27, and 39	NE	NE	Moderate	Yes	NE	Suggested
FAB	33 and 34	Moderate	High	High	NE	NE	Suggested
D‐KEFS VF	25, 26, 27, 34, and 36	Low to moderate	NE	Moderate to high	NE	NE	Suggested
HVLT	31	High	NE	NE	NE	NE	Suggested
TPCT	23, 27, and 33	High	NE	NE	NE	NE	Suggested
MMSE	22, 23, 24, 25, 26, 27, 28, 31, 32, 33, 34, 35, 36, and 37	Low to moderate	High	High	Low for small changes	1.4 points	Listed
QTCS	22	NE	NE	NE	NE	NE	Listed
VMI	31	NE	NE	NE	NE	NE	Listed
BTA	26 and 31	NE	NE	NE	NE	NE	Listed

Endorsement definitions: (1) “Recommended”: The outcome measure has been applied to PDD patients and has been found valid, reliable, and responsive in psychometric studies in studies of PDD or other dementias; (2) “Suggested”: The outcome measure has been applied to PDD patients and psychometric studies are promising (“moderate” to “high” parameters), but not yet complete in dementia populations and/or some psychometric properties are suboptimal (“low”); and (3) “Listed”: The outcome measure has been applied to PDD patients, but psychometric studies have demonstrated disappointing data (“low” parameters) and/or have not yet been performed in dementia populations.

QTCS, Quick Test of Cognitive Speed; VMI, Developmental Test of Visual‐Motor Integration; BTA, Brief Test of Attention; PDD, Parkinson's disease dementia; NE, Not established.